A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment

Michael I. Fingerhood, Van L King, Robert K. Brooner, Darius A. Rastegar

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background: The purpose of this study was to compare demographic factors and 1-year treatment outcomes of patients treated with buprenorphine or methadone. Methods: The study included 252 subjects who received a prescription for buprenorphine in an academic internal medicine practice and 252 subjects who enrolled in a methadone maintenance program located on the same campus over the same time frame. Data were collected retrospectively. Patients were classified as "opioid-positive" or "opioid-negative" each month for a year based on urine drug testing and provider assessment. Successful treatment was defined as remaining in treatment after 1 year and achieving 6 or more opioid-negative months. Results: Buprenorphine patients were more likely to be male, have health insurance, be employed, abuse prescription opioids, and be human immunodeficiency virus (HIV) infected; they were less likely to abuse benzodiazepines. At 12 months, 140 (55.6%) of buprenorphine patients and 156 (61.9%) of methadone patients remained in treatment (P =.148). Patients on methadone had a higher mean number of opioid-negative months (6.96 vs. 5.43; P <.001) and mean number of months in treatment (9.38 vs. 8.59; P <.001). On multivariable analysis, methadone maintenance was significantly associated with successful treatment (adjusted odds ratio: 2.10; 95% confidence interval: 1.43-3.07). Conclusions: Office-based buprenorphine and methadone maintenance programs serve very different populations. Both are effective, but patients on methadone had mildly better treatment outcomes.

Original languageEnglish (US)
Pages (from-to)122-126
Number of pages5
JournalSubstance Abuse
Volume35
Issue number2
DOIs
StatePublished - Apr 3 2014
Externally publishedYes

Fingerprint

Buprenorphine
Methadone
Opioid Analgesics
Therapeutics
Prescriptions
Health Insurance
Internal Medicine
Benzodiazepines
Odds Ratio
Demography
HIV
Urine
Confidence Intervals
Pharmaceutical Preparations
Population

Keywords

  • Buprenorphine
  • methadone
  • opioid-dependent
  • treatment

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health
  • Medicine(all)

Cite this

A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment. / Fingerhood, Michael I.; King, Van L; Brooner, Robert K.; Rastegar, Darius A.

In: Substance Abuse, Vol. 35, No. 2, 03.04.2014, p. 122-126.

Research output: Contribution to journalArticle

@article{fffda202543a4df0bdf028c229b10ce7,
title = "A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment",
abstract = "Background: The purpose of this study was to compare demographic factors and 1-year treatment outcomes of patients treated with buprenorphine or methadone. Methods: The study included 252 subjects who received a prescription for buprenorphine in an academic internal medicine practice and 252 subjects who enrolled in a methadone maintenance program located on the same campus over the same time frame. Data were collected retrospectively. Patients were classified as {"}opioid-positive{"} or {"}opioid-negative{"} each month for a year based on urine drug testing and provider assessment. Successful treatment was defined as remaining in treatment after 1 year and achieving 6 or more opioid-negative months. Results: Buprenorphine patients were more likely to be male, have health insurance, be employed, abuse prescription opioids, and be human immunodeficiency virus (HIV) infected; they were less likely to abuse benzodiazepines. At 12 months, 140 (55.6{\%}) of buprenorphine patients and 156 (61.9{\%}) of methadone patients remained in treatment (P =.148). Patients on methadone had a higher mean number of opioid-negative months (6.96 vs. 5.43; P <.001) and mean number of months in treatment (9.38 vs. 8.59; P <.001). On multivariable analysis, methadone maintenance was significantly associated with successful treatment (adjusted odds ratio: 2.10; 95{\%} confidence interval: 1.43-3.07). Conclusions: Office-based buprenorphine and methadone maintenance programs serve very different populations. Both are effective, but patients on methadone had mildly better treatment outcomes.",
keywords = "Buprenorphine, methadone, opioid-dependent, treatment",
author = "Fingerhood, {Michael I.} and King, {Van L} and Brooner, {Robert K.} and Rastegar, {Darius A.}",
year = "2014",
month = "4",
day = "3",
doi = "10.1080/08897077.2013.819828",
language = "English (US)",
volume = "35",
pages = "122--126",
journal = "Substance Abuse",
issn = "0889-7077",
publisher = "Routledge",
number = "2",

}

TY - JOUR

T1 - A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment

AU - Fingerhood, Michael I.

AU - King, Van L

AU - Brooner, Robert K.

AU - Rastegar, Darius A.

PY - 2014/4/3

Y1 - 2014/4/3

N2 - Background: The purpose of this study was to compare demographic factors and 1-year treatment outcomes of patients treated with buprenorphine or methadone. Methods: The study included 252 subjects who received a prescription for buprenorphine in an academic internal medicine practice and 252 subjects who enrolled in a methadone maintenance program located on the same campus over the same time frame. Data were collected retrospectively. Patients were classified as "opioid-positive" or "opioid-negative" each month for a year based on urine drug testing and provider assessment. Successful treatment was defined as remaining in treatment after 1 year and achieving 6 or more opioid-negative months. Results: Buprenorphine patients were more likely to be male, have health insurance, be employed, abuse prescription opioids, and be human immunodeficiency virus (HIV) infected; they were less likely to abuse benzodiazepines. At 12 months, 140 (55.6%) of buprenorphine patients and 156 (61.9%) of methadone patients remained in treatment (P =.148). Patients on methadone had a higher mean number of opioid-negative months (6.96 vs. 5.43; P <.001) and mean number of months in treatment (9.38 vs. 8.59; P <.001). On multivariable analysis, methadone maintenance was significantly associated with successful treatment (adjusted odds ratio: 2.10; 95% confidence interval: 1.43-3.07). Conclusions: Office-based buprenorphine and methadone maintenance programs serve very different populations. Both are effective, but patients on methadone had mildly better treatment outcomes.

AB - Background: The purpose of this study was to compare demographic factors and 1-year treatment outcomes of patients treated with buprenorphine or methadone. Methods: The study included 252 subjects who received a prescription for buprenorphine in an academic internal medicine practice and 252 subjects who enrolled in a methadone maintenance program located on the same campus over the same time frame. Data were collected retrospectively. Patients were classified as "opioid-positive" or "opioid-negative" each month for a year based on urine drug testing and provider assessment. Successful treatment was defined as remaining in treatment after 1 year and achieving 6 or more opioid-negative months. Results: Buprenorphine patients were more likely to be male, have health insurance, be employed, abuse prescription opioids, and be human immunodeficiency virus (HIV) infected; they were less likely to abuse benzodiazepines. At 12 months, 140 (55.6%) of buprenorphine patients and 156 (61.9%) of methadone patients remained in treatment (P =.148). Patients on methadone had a higher mean number of opioid-negative months (6.96 vs. 5.43; P <.001) and mean number of months in treatment (9.38 vs. 8.59; P <.001). On multivariable analysis, methadone maintenance was significantly associated with successful treatment (adjusted odds ratio: 2.10; 95% confidence interval: 1.43-3.07). Conclusions: Office-based buprenorphine and methadone maintenance programs serve very different populations. Both are effective, but patients on methadone had mildly better treatment outcomes.

KW - Buprenorphine

KW - methadone

KW - opioid-dependent

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=84901236908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901236908&partnerID=8YFLogxK

U2 - 10.1080/08897077.2013.819828

DO - 10.1080/08897077.2013.819828

M3 - Article

VL - 35

SP - 122

EP - 126

JO - Substance Abuse

JF - Substance Abuse

SN - 0889-7077

IS - 2

ER -